ANAVEX LIFE SCIENCES CORP. Travel and Entertainment Expense
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Travel and Entertainment Expense of $12.02 thousand for the 3-month period ending 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TravelAndEntertainmentExpense · last filed 2014-02-14
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for the quarter ending 2013-12-31 was $12.02K.
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for the quarter ending 2013-09-30 was $14.13K, a 76.47% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for the quarter ending 2013-06-30 was $5.37K, a 20.36% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for the quarter ending 2013-03-31 was $187.00, a 99.40% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for fiscal 2013 was $19.70K, a 70.53% decline from fiscal 2012.
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for fiscal 2012 was $66.84K, a 63.33% decline from fiscal 2011.
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for fiscal 2011 was $182.26K, a 22.86% decline from fiscal 2010.
- ANAVEX LIFE SCIENCES CORP. travel and entertainment expense for fiscal 2010 was $236.27K.
| Period end | Travel and Entertainment Expense 3 month | Travel and Entertainment Expense 6 month | Travel and Entertainment Expense 9 month | Travel and Entertainment Expense 12 month | Travel and Entertainment Expense 89 month | Travel and Entertainment Expense 92 month | Travel and Entertainment Expense 95 month | Travel and Entertainment Expense 98 month | Travel and Entertainment Expense 101 month | Travel and Entertainment Expense 104 month | Travel and Entertainment Expense 107 month | Travel and Entertainment Expense 110 month | Travel and Entertainment Expense 113 month | Travel and Entertainment Expense 116 month | Travel and Entertainment Expense 119 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $12.02K 10-Q · filed 2014-02-14 | $26.16K derived: sum of 2 quarters · filed 2014-02-14 | $31.53K derived: sum of 3 quarters · filed 2014-02-14 | $31.72K derived: sum of 4 quarters · filed 2014-02-14 | $772.87K 10-Q · filed 2014-02-14 | ||||||||||
| 2013-09-30 | $14.13K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $19.51K derived: sum of 2 quarters · filed 2013-12-30 | $19.70K derived: sum of 3 quarters · filed 2013-12-30 | $19.70K 10-K · filed 2013-12-30 | $760.85K 10-K · filed 2013-12-30 | ||||||||||
| 2013-06-30 | $5.37K 10-Q · filed 2013-08-14 | $5.56K derived: sum of 2 quarters · filed 2013-08-14 | $5.56K 10-Q · filed 2013-08-14 | $13.57K derived: sum of 4 quarters · filed 2014-02-14 | $746.72K 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $187.00 10-Q · filed 2013-05-17 | $187.00 10-Q · filed 2013-05-17 | $8.20K derived: sum of 3 quarters · filed 2014-02-14 | $12.66K derived: sum of 4 quarters · filed 2014-02-14 | $741.34K 10-Q · filed 2013-05-17 | ||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $8.01K derived: sum of 2 quarters · filed 2014-02-14 | $12.47K derived: sum of 3 quarters · filed 2014-02-14 | $43.67K derived: sum of 4 quarters · filed 2014-02-14 | $741.15K 10-Q · filed 2013-02-14 | ||||||||||
| 2012-09-30 | $8.01K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $12.47K derived: sum of 2 quarters · filed 2013-12-30 | $43.67K derived: sum of 3 quarters · filed 2013-12-30 | $66.84K 10-K · filed 2013-12-30 | $741.15K 10-K · filed 2012-12-31 | ||||||||||
| 2012-06-30 | $4.46K 10-Q · filed 2013-08-14 | $35.66K derived: sum of 2 quarters · filed 2013-08-14 | $58.83K 10-Q · filed 2013-08-14 | $129.47K derived: sum of 4 quarters · filed 2013-08-14 | $733.14K 10-Q · filed 2012-08-17 | ||||||||||
| 2012-03-31 | $31.20K 10-Q · filed 2013-05-17 | $54.36K 10-Q · filed 2013-05-17 | $125.01K derived: sum of 3 quarters · filed 2013-05-17 | $184.87K derived: sum of 4 quarters · filed 2013-05-17 | $728.68K 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $23.16K 10-Q · filed 2013-02-14 | $93.81K derived: sum of 2 quarters · filed 2013-02-14 | $153.67K derived: sum of 3 quarters · filed 2013-02-14 | $173.70K derived: sum of 4 quarters · filed 2013-02-14 | $697.48K 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | $70.64K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $130.51K derived: sum of 2 quarters · filed 2012-12-31 | $150.53K derived: sum of 3 quarters · filed 2012-12-31 | $182.26K 10-K · filed 2012-12-31 | $674.32K 10-K · filed 2011-12-22 | ||||||||||
| 2011-06-30 | $59.86K 10-Q · filed 2012-08-17 | $79.89K derived: sum of 2 quarters · filed 2012-08-17 | $111.61K 10-Q · filed 2012-08-17 | $603.67K 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $20.03K 10-Q · filed 2012-05-15 | $51.75K 10-Q · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $31.73K 10-Q · filed 2012-02-14 | ||||||||||||||
| 2010-09-30 | $236.27K 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |